Ovarian hyperstimulation syndrome management strategies: where are we going?
Minerva Endocrinol
; 43(1): 50-56, 2018 Mar.
Article
em En
| MEDLINE
| ID: mdl-28322539
ABSTRACT
Ovarian hyperstimulation syndrome (OHSS) is one of the most frequent, serious and potentially lethal iatrogenic complications of controlled ovarian stimulation. Despite extensive research, the exact pathogenesis of this syndrome remains less clear, but there appears to be a relationship of increased vascular permeability mediated by HCG and other downstream mediators. Adequate experience with ovulation induction therapy and identifying patients with known risk factors are essential in preventing OHSS. As this is a completely iatrogenic disease numerous strategies have been investigated to help decrease the risk of OHSS and their effects on pregnancy and live birth rate. What follows is a review of the common strategies apply today to minimize risk of OHSS in patients undergoing assisted reproductive technologies.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndrome de Hiperestimulação Ovariana
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Minerva Endocrinol
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Estados Unidos